IMCR Stock: Price, Earnings History and SEC Filings
Immunocore Holdings plc (IMCR) last traded at $30.49, down 2.49% on the latest session and up 0.7% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.02 against an analyst estimate of $-0.01, a miss of 100.0%.
$30.49 -2.49%
1 month+0.66%
52-week high$40.72
52-week low$27.50
Volume290,233
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
IMCR earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.02 | $-0.01 | -100.00% |
| Mar 2026 | May 6, 2026 | $0.25 | $-0.26 | +196.15% |
| Dec 2025 | Feb 25, 2026 | $-0.60 | $-0.28 | -114.29% |
| Sep 2025 | Nov 6, 2025 | $0.00 | $-0.30 | +100.00% |
IMCR beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for IMCR
SEC filing data is not available right now. You can search for IMCR on SEC EDGAR.
IMCR news
- Immunocore will present Phase 1 data for brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma, during a late-breaking oral session at the 2026 SITC meetingOct 29, 2026 · finance.yahoo.com
- Should First Type 1 Diabetes Dosing Require Action From Immunocore Stock Investors?Oct 29, 2026 · finance.yahoo.com
About Immunocore Holdings plc
Immunocore Holdings plc (IMCR) is a US-listed public company on Nasdaq.